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1. Introduction
Bacterial infections are still major factors of mor-
bidity and mortality in both developing and devel-
oped countries worldwide therefore, antibiotics 
should be considered medicines of special impor-
tance [1]. In addition to being the causal therapy of 
often life-threatening infections (e.g., sepsis), anti-
biotics have paved the way for the development of 
many medical specialities (e.g., complex surgical 
procedures, organ transplantation, cancer chemo-
therapy, neonatology) [2, 3]. The continuous emer-
gence of resistance bacterial strains (especially 
multidrug-resistant [MDR] pathogens) is becoming 
a severe global health issue [4,5]. One of the best 
ways to combat antimicrobial drug resistance is 
with the development of novel antibiotic drugs 
(which was the standard course of conduct during 
the 1960-1980’s), nowadays however, the pharma-
ceutical companies are struggling to keep up with 
the continuous and detrimental developments in 
resistance trends [6,7]. The scarcity of new agents 
in the ‘antibiotic pipeline’ could be attributed to 
economical (antibiotics have high developmental 
costs and modest returns of investment, develop-
ment of drugs for chronic illnesses and cancer is 
much more lucrative), clinical (the difficulties of ar-
ranging and tracking clinical trials) and microbio-
logical (the emergence of resistant strains is inevi-
table) characteristics [8,9]. For this reason, no novel 
broad-spectrum agent has been developed since 
the discovery of the fluoroquinolones in the 1980’s, 
while the dynamic increase in the prevalence of re-
sistant isolates has been reported worldwide [10].
Due to the scarcity of available therapeutic op-
tions, novel strategies have been proposed to com-
bat bacterial pathogens more effectively [11,12]. 
One of these strategies is combination therapy 
with the use of existing antibiotics, however, ex-
cept for some well-defined clinical situations, the 
clinical utility of antibiotic combinations has been 
controversial, in addition to their costs for the 
healthcare infrastructure [13]. Another possible 
therapeutic alternative is to utilize adjuvant com-
pounds (together with antibiotics) during therapy 
[12,14]. These antimicrobial adjuvants are classi-
fied to two distinct categories: Class I adjuvants af-
fect the microorganism, while Class II adjuvants 
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affect the cells of the host. Class I adjuvants in-
clude examples, such as β-lactamase inhibitors 
(which have been successfully used in therapy for 
many decades against various β-lactamase-
producing pathogens), bacterial efflux pump in-
hibitors (e.g., phenylalanine-arginine β-naphthy-
lamide (PAβN, although these compounds only 
have relevance in theoretical models and experi-
mental settings for now, because most of them are 
toxic in the efflux pump inhibitory concentra-
tions)) and modulators of bacterial membrane po-
tential (e.g., loperamide) and compounds inhibit-
ing bacterial toxin synthesis or neutralizing anti-
bodies (e.g., bezlotoxumab against the toxins of 
Clostridioides difficile) [14,15]. Class I adjuvants 
may be useful, as they may in theory, make old 
antibiotics useful again, that have already been 
eliminated from clinical practice due to their 
widespread resistance. Class II adjuvants are usu-
ally compounds enhancing the immune response 
of the host organism against the foreign invaders 
(e.g., streptazolin, as a stimulant of macrophages 
and natural killer-cells) [14]. Another promising 
approach to fight bacterial infections is the use of 
virulence inhibitors: these compounds do not af-
fect the viability of these cells, instead, they inhibit 
the synthesis or expression of bacterial virulence 
factors, which are key in their pathogenesis [16]. 
The potential advantage of these agents is that the 
selection pressure (and consequently, the chance 
of resistance development) is expected to be much 
lower [17].
Quorum sensing (QS; also called autoinduction) 
is a chemical-sociobiologi-
cal mechanism of commu-
nication, during which 
bacteria can regulate the 
expression of specific 
genes (which are impor-
tant for benefits in fitness 
and reproductive success 
in their niche), in re-
sponse to the density of 
cells in the surrounding 
environment [18,19]. This 
includes the detection of 
signal molecules pro-
duced by surrounding 
cells and also self-pro-
duced signals (leading to 
positive feed-back; these 
autoinducers (or bacterial 
‘pheromones’) diffuse 
into the specific niche, where their concentrations 
grow proportionally with the number of bacterial 
cells [20]. If the concentration of these signal mol-
ecules reaches a critical concentration (corre-
sponding to a critical population density), these 
signal molecules initiate the transcription of vari-
ous target genes [18-20]. Quorum sensing was first 
described in the marine bacterium Vibrio fischeri, a 
symbiont in the light organ of some marine ani-
mals: if bacteria reach a threshold population den-
sity, genes encoding bioluminescence are ex-
pressed [21]. QS mediates the expression of vari-
ous features important in bacterial physiology 
and virulence, leading to phenotypic changes: ex-
pression of toxin genes (e.g., toxic shock syn-
drome toxin in Staphylococcus aureus, elastase in 
Pseudomonas aeruginosa, protease in V. cholerae), 
bacterial secretion systems (e.g., Salmonella spe-
cies), efflux pumps (e.g., P. aeruginosa), biofilm-
production (e.g., P. aeruginosa, Acinetobacter bau-
mannii), induction of bacterial competence (Strep-
tococcus pneumoniae), motility (e.g., P. aeruginosa) 
and production of pigments (e.g., Chromobacterium 
violaceum, Serratia marcescens) [22-27]. Quorum 
sensing has also been implicated in facilitating the 
spread of antibiotic-resistance genes [18,28-30].
QS signal molecules include a wide range of 
compounds with distinct structural characteristics 
[18-20]. In Gram-negative bacteria, derivatives of 
L-homoserine lactone (acyl-HSLs or AHLs) are the 
most prevalent, while in Gram-positive bacteria, 
peptide-based signal molecules (autoinducing 
peptides, AIPs, which are post-transcriptionally 
Figure 1 Examples of quorum sensing signal molecules (autoinducers) [18-27, 31]
A: Acyl-homoserine-lactones (AHL); B: Butanoyl-homoserine-lactones (BHL); C: 
Autoinducer-2 (AI); D: Indole; E: Cholera autoinducer (CAI-1/V. cholerae); F: 
Pseudomonas quinolone signal (PQS); G: Diffusible signal factor (DSF)
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modified small peptides) are most frequently de-
tected. Some signaling molecules are detected by 
both groups (e.g., AI-2, a derivative of dihy-
droxy-2,3-pentanedione) (for examples, see Figure 1) 
[18-23]. Although the signal molecules may differ, 
the consequent mechanism of activation caused by 
these molecules is very similar in all bacteria [18-
23]. In Gram-negative bacteria AHLs may be char-
acterized by the nature and length of the substitu-
tion at the 3-carbon position, and the presence of 
unsaturated chains within the acyl chain [18,19,31].
The elimination or inhibition of QS-signal trans-
mission is termed quorum quenching (QQ) [32]. 
This may be a consequence of inhibition of autoin-
ducer-synthesis, degradation of signal molecule or 
through the use of signal-antagonists, inhibiting the 
sensing of these signal molecules by the relevant 
bacteria [19,31,32]. It is no surprise that many or-
ganisms possess enzymes with activity against such 
signal molecules (e.g., the human paraoxonase 
(PON, a lactonase) can also degrade AHLs). Syn-
thetic compounds (inhibition-based QQ) or en-
zymes (degradation-based QQ) do not kill patho-
genic bacteria, instead they inhibit the signal trans-
duction mechanisms important in the expression of 
their virulence determinants (thus, disarming 
them) [14,16,19,31,32]. QQ-compounds may be con-
sidered as potential therapeutic alternatives in the 
treatment of bacterial infections, as they are capable 
of eliminating the disease-causing capacity of bacte-
ria, without the risk of rapid resistance develop-
ment [18-20, 31-33]. Several in vitro and in vivo mod-
el systems have been developed for the qualitative 
and quantitative evaluation of a compounds QS-in-
hibitory activity: these methods may include the 
use of Petri-dish or microplate-based colorimetric 
methods, molecular biological techniques (e.g., 
polymerase chain reaction), animal models and 
transgenic constructs [34-36]. Disk diffusion is a 
simple method for screening the susceptibility of 
various microorganisms against drugs/candidate 
molecules: it is user-friendly, and there is a lot of 
experience accumulated due to its use in routine 
clinical microbiology. Disk-diffusion based QS-in-
hibitory (DDBQSI) assay utilizing QS-signal mole-
cule producing strains and signal molecule-report-
er strains (e.g., Agrobacterium, Chromobacterium, 
Pseudomonas, Serratia and Vibrio species) is the most 
frequently used method [36-40]. The advantage of 
this method is its simple execution, the high-
throughput nature and its usability in resource-
scarce settings [41]. Nevertheless, there are many 
different and conflicting experimental protocols 
described for DDBQSI-assays in the literature, 
which makes it difficult to evaluate and compare 
published results. Additionally, the reproducibility 
of positive results still represents an important 
challenge for laboratories, because growth charac-
teristics and pigment production by these bacteria 
is also subject to some additional factors [37]. The 
aim of the present study is to determine the ideal 
experimental conditions (i.e., incubation time, tem-
perature, culture media) for disk-diffusion based 
QS-inhibitory (DDBQSI) assays with the most fre-
quently used QS-signal molecule producing and 
reporter strains, and to establish standard operat-
ing procedures (SOPs) to optimize reproducibility 
of these assays.
2. Materials and methods
2.1. Culture media
 − Mueller-Hinton broth (MH-B) and Mueller-Hin-
ton agar (MH-A) (Bio-Rad Hungary Ltd., Buda-
pest, Hungary)
 − Nutrient broth (NB) and Nutrient agar (NA) 
(Bio-Rad Hungary Ltd., Budapest, Hungary)
 − Luria-Bertani broth (LB-B) and Luria-Bertani 
agar (LB-A) Bio-Rad Hungary Ltd., Budapest, 
Hungary)
 − Modified Luria-Bertani broth (LB*-B) and agar 
(LB*-A) (which were prepared in-house, con-
taining 8.0 g tryptone, 5.0 g yeast extract, 5.0 g 
NaCl, 2.0 g glucose, 1.0 g K2HPO4, 0.2 g MgSO4 x 
7H2O, 10 mL 3% CaCl2 stock solution, 5 mL Fe-
EDTA stock solution, 1 mL microelement stock 
solution and 12.0 g of bacteriological agar in 
case of the solid medium, per 1 L of media; pH 
was adjusted to 7.0-7.2)
2.2. Bacterial strains
The following bacterial strains were used during 
our experiments: 
 − Chromobacterium violaceum wt85 [36]
Taxomony: Gram-negative, facultative anaerobic 
rod, member of the Neisseriales order 
Function: wild-type strain (control strain), char-
acterized by the AHL signal molecule-mediated 
production of the purple violacein pigment, ca-
pable of endogenous QS-signal molecule-pro-
duction (N-hexanoyl-L-HSL)
 − C. violaceum CV026 [36]
axomony: Gram-negative, facultative anaerobic 
rod, member of the Neisseriales order
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Function: Tn5 transposase-mutant, AHL-signal 
molecule indicator strain (produces purple vio-
lacein pigment in the presence of AHLs), which 
is incapable of endogenous QS-signal molecule-
production, but useful in the detection of exter-
nal stimuli
 − Enterobacter cloacae (clinical isolate no. 31298, 
isolated from a wound sample) [37]
Taxomony: Gram-negative, facultative anaerobic 
rod, member of the Enterobacterales order
Function: AHL-producing-strain (used with C. 
violaceum CV026)
 − Sphingomonas paucimobilis Ezf 10-17 (isolated 
from a tumor of the “Ezertűfű” variety of the 
common grape vine [Vitis vinifera]) [36]
Taxomony: Gram-negative, strict aerobic rod, 
member of the Sphingomonadales order
Function: AHL-producing-strain (used with C. 
violaceum CV026)
 − Novosphingobium spp. Rr 2-17 (isolated from a 
tumor of the “Rajnai rizling” variety of the 
common grape vine [Vitis vinifera]) [36]
Taxonomy: Gram-negative, facultative anaerobic 
rod, member of the member of the Sphingo-
monadales order
Function: AHL-producing-strain (used with C. 
violaceum CV026)
 − Serratia marcescens AS-1 (Szeged Microbiological 
Culture Collection) [39]
Taxonomy: Gram-negative, facultative anaerobic 
rod, member of the Enterobacterales order
Function: characterized by the production AHL 
signal molecule-mediated production of the or-
ange-red pigment prodigiosin (2-methyl-3-pen-
tyl-6-methoxyprodigiosin), capable of endoge-
nous QS-signal molecule-production (N-hex-
anoyl-L-HSL)
 − A. tumefaciens NTL4(pCF218)(pCF372) (isolated 
from a tumor of a wild cherry tree [Prunus avi-
um]) [36,38]
Taxonomy: Gram-negative, facultative anaerobic 
rod, member of the Rhizobiales order
Function: characterized by the expression of 
β-galactosidase in the presence of a wide range 
of AHL signals, which may be detected in the 
presence of X-gal (5-bromo-4-chloro-3-indolyl-
β-D-galactopyranoside) in the medium, result-
ing in a color change
 − A. tumefaciens C58 [36,38]
Taxonomy: Gram-negative, facultative anaerobic 
rod, member of the Rhizobiales order
Function: AHL-producing-strain (used with Agro-
bacterium tumefaciens NTL4(pCF218)(pCF372))
The bacterial strains for our experiments were 
kindly provided by Dr. Ernő Szegedi (Institute of 
Viticulture and Enology, National Agricultural 
Research Center). The bacterial strains were main-
tained on Luria-Bertani (LB) agar for shorter time 
periods (<1 month), while for longer periods, the 
strains were kept in a -80°C freezer, in a 1:4 mix-
ture of 85% glycerol and liquid Luria-Bertani me-
dia. For the maintenance purposes of C. violaceum 
CV026 and A. tumefaciens NTL4(pCF218)(pCF372), 
media were also supplemented with kanamycin 
and carbenicillin, respectively [36,38].
2.3. Chemicals
Bacteriological agar (Bio-Rad Hungary Ltd.; Buda-
pest, Hungary), tryptone (Thermo Fischer Scien-
tific; Waltham, US), yeast extract (Thermo Fischer 
Scientific; Waltham, US), D-glucose (Sigma-Aldi-
ch; Budapest, Hungary), kanamycin (Sigma-Aldi-
ch; Budapest, Hungary), carbenicillin (Sigma-Al-
dich; Budapest, Hungary), NaCl (Sigma-Aldich; 
Budapest, Hungary), K2HPO4 (Sigma-Aldich; Bu-
dapest, Hungary), KH2PO4 (Sigma-Aldich; Buda-
pest, Hungary), MgSO4x7H20 (Sigma-Aldich; Bu-
dapest, Hungary), CaCl2x2H2O (Sigma-Aldich; Bu-
dapest, Hungary), FeSO4x7H20 (Sigma-Aldich; Bu-
dapest, Hungary), Na2EDTA (Sigma-Aldich; Buda-
pest, Hungary), MnSO4x7H2O (Sigma-Aldich; 
Budapest, Hungary), ZnSO4x7H2O (Sigma-Aldich; 
Budapest, Hungary), Na2MoO4x2H2O (Sigma-Al-
dich; Budapest, Hungary), CoCl2x6H2O (Sigma-Al-
dich; Budapest, Hungary), dimethyl-sulfoxide 
(DMSO; Sigma-Aldich; Budapest, Hungary), acri-
dine orange (Sigma-Aldich; Budapest, Hungary) 
and phosphate buffered saline (PBS; Sigma-Aldi-
ch; Budapest, Hungary). During the preparation 
of the modified Luria-Bertani broth (LB*-B) and 
agar (LB*-A), the following stock solutions were 
used: 5% Fe-EDTA stock solution, 3% CaCl2 stock 
solution and a microelement stock solution (con-
taining 1.0 g MnSO4x7H2O, 0.5 g ZnSO4x7H2O, 25 
mg Na2MoO4x2H2O and 2.5 mg CoCl2x6H2O per 
100 mL). The stock solutions were aliquoted in 50 
mL centrifuge tubes and kept at -20°C.
2.4. Evaluation of growth characteristics and pigment 
production of relevant bacterial strains
To identify the ideal experimental conditions, 
growth characteristics of the bacterial strains used 
were determined in Nutrient broth (NB), Mueller-
Hinton (MH-B) and Luria-Bertani (LB-B) broths, 
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in addition to Nutrient 
agar (NA), Mueller-Hin-
ton (MH-A) agar and Lu-
ria-Bertani agar (LB-A). In 
the assays, liquid and sol-
id media were inoculated 
with the same primary 
culture for each bacterial 
strain using a calibrated 
loop (10 µl). The optical 
density of the liquid me-
dia (OD580, using a pho-
tometer) and the number 
of colonies as well as the 
degree of pigment pro-
duction were observed. 
Growth properties were 
studied at four different temperatures of incuba-
tion: 0°C (refrigerator), 10°C (cooled room with 
controlled temperature), 25°C (room temperature) 
and 37°C (incubator). The cultures were mea-
sured/read after 12, 24, 48 and 72 hours of incuba-
tion. The results of the experiments were from at 
least three independent experiments. Based on lit-
erature data, our study was later complemented 
with a modified Luria-Bertani (LB*) medium, 
which was compared to the classical LB medium 
[42] (see 2.1. Culture media).
2.5. Disk diffusion quorum-sensing inhibitory assay
Quorum sensing inhibitory activity was monitored 
by the disk diffusion method. During the assay, 
cultures of OD580~0.5 overnight bacteria grown in 
LB*-B broth were inoculated directly onto LB*-A 
agar surface. Filter paper disks (7.0 mm in diameter, 
Whatmann 3MM), were impregnated with 10 µL of 
acridine orange (AO; used as a positive control; 25.0 
mg/mL in phosphate buffered saline) or DMSO 
(used as a negative control, 2 V/V%) [37]. The disks 
were placed on the surface of LB*-A agar surface 
between the parallel inoculations of sensor (C. vio-
laceum CV026) and AHL-producer (S. paucimobilis 
Ezf 10-17, Novosphingobium spp. Rr 2-17 and E. cloa-
cae 31298) strains; the exception was S. marcescens 
AS-1 (capable of producing prodigiosin from en-
dogenous AHL-signals), where disks were placed 
on the center of the inoculated line (Figure 2) [36-
39]. To quantify the QS inhibitory effect, the diam-
eter of the QS-inhibition zones (i.e., the culture of 
discolored but intact bacteria) around the disks 
was measured using a ruler, after 12, 24, 48 and 72 
hours of incubation [36-39]. The results of the 
studies are derived from the average of at least 
three independent experiments. The A. tumefa-
ciens NTL4(pCF218)(pCF372) and A. tumefaciens 
C58 indicator-AHL-producer pair was not includ-
ed in this experiment, as the presence of X-gal is 
required in the media for the colour change to oc-
cur.
3. Results and discussion
3.1. Growth characteristics of bacterial strains
There were no relevant differences detected in the 
growth rate of bacterial strains between the differ-
ent liquid broths (NB, MH, LB). The growth of 
bacterial strains was inhibited at low tempera-
tures (0 and 10 ° C) resulting in OD580 values of 
0-0.05, 0.05-0.1 and 0.1-0.2 for 12, 24, 48 and 72 
hours of incubation, respectively, which was inad-
equate to perform further experiments. There was 
no difference in bacterial growth between 25°C 
and 37°C incubations (resulting in OD580 values of 
0.4-0.5 after 12 hours (i.e. overnight), 0.8-1 after 24 
hours, and >1 after 48 hours), except in the case of 
C. violaceum wt85 and C. violaceum CV026, where 
higher reads were observed at 37°C, but in both 
cases, the OD of the bacterial cultures was appro-
priate for performing further experiments. The 
use of 48 hour- and 72 hour-cultures is not recom-
mended, due to the accumulation of dead bacteri-
al cells and autolysis, a consequence of the deple-
tion of nutrients in the culture media (in fact, the 
OD580 values after 72 hours showed decreasing 
tendencies), which may lead to distorted results in 
the experiments later on. Similarly, there were no 
relevant differences detected in the growth rate of 
Figure 2 Disk diffusion quorum-sensing inhibitory assay using C. violaceum CV026 and 
E. cloacae 31298 (left) and S. marcescens AS-1 (right)
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bacterial strains between the solid agar media 
(NB, MH-B and LB-B). It should be highlighted, 
that in case of S. marcescens, the temperature had a 
pronounced effect on pigment production in both 
liquid and solid media (pigment production 
ceased at 37°C, this effect was not observed for C. 
violaceum wt85). For this reason, 25°C was set as 
the reference temperature for the additional ex-
periments. 
Based on previous reports, it was found that the 
concentration of several metal ions in the environ-
ment has a pronounced effect of quorum sensing 
in bacteria [37]. After a thorough literature survey, 
an additional medium was included in our opti-
mization studies, namely the modified LB (or LB*) 
broth and solid media, which is supplemented by 
additional nutrients and a microelement solution 
(containing various metal ions) [42]. The tested 
strains showed no relevant differences in the 
growth characteristics in LB-B and LB*-B broths in 
the same experimental setup previously de-
scribed. However, during the comparison of LB-A 
and LB*-A solid media, it was evident that colony 
formation (number and size of bacterial colonies) 
and pigmentation of the colonies occurred more 
rapidly, therefore, the growth properties of the 
relevant strains were further characterized on this 
media (Table I). During the bacterial growth exper-
iments on the LB*-A solid media, it was observed 
that bacterial colonies’ growth and pigment pro-
duction on LB * agar were stable after 48 hours 
when incubated at 25°C. In addition, if the read-
Table I Growth characteristics of tested QS-strains on LB*-A media at room temperature (25 °C)
Optical density (OD580 ) of bacterial inoculum used
After 24 hours 0.1 0.3 0.5 0.7 1.0
Chromobacterium violaceum CV026 ø ø /+ + + ++
Chromobacterium violaceum wt85 ø ø/+ + + ++ (!)
Sphingomonas paucimobilis Ezf 10-17 ø/+ ø/+ + ++ ++
Novosphingobium spp. Rr 2-17 ø ø ø + +
Serratia marcescens AS-1 ++ ++ +++ +++ +++
Enterobacter cloacae 31298 ++ ++ ++ +++ +++
Agrobacterium tumefaciens NTL4 -/+ -/+ + ++ ++
Agrobacterium tumefaciens C58 -/+ -/+ + ++ ++
After 48 hours 0.1 0.3 0.5 0.7 1
Chromobacterium violaceum CV026 ++ +++ +++ +++ +++
Chromobacterium violaceum wt85 +++ (!) +++ (!) +++ (!) +++ (!) +++ (!)
Sphingomonas paucimobilis Ezf 10-17 ++ ++ +++ +++ +++
Novosphingobium spp. Rr 2-17 ++ ++ ++ ++ +++
Serratia marcescens AS-1 +++ (!) +++ (!) ++++ (!) ++++ (!) ++++ (!)
Enterobacter cloacae 31298 +++ +++ +++ +++ +++
Agrobacterium tumefaciens NTL4 +++ +++ +++ +++ +++
Agrobacterium tumefaciens C58 +++ +++ +++ +++ +++
After 72 hours 0.1 0.3 0.5 0.7 1
Chromobacterium violaceum CV026 +++ +++ +++ +++ +++
Chromobacterium violaceum wt85 +++ (!) +++ (!) +++ (!) +++ (!) +++ (!)
Sphingomonas paucimobilis Ezf 10-17 +++ +++ +++ +++ +++
Novosphingobium spp. Rr 2-17 ++ +++ +++ ++++ ++++
Serratia marcescens AS-1 +++ (!) +++ (!) ++++ (!) ++++ (!) ++++ (!)
Enterobacter cloacae 31298 +++ +++ ++++ ++++ ++++
Agrobacterium tumefaciens NTL4 +++ +++ ++++ ++++ ++++
Agrobacterium tumefaciens C58 +++ +++ ++++ ++++ ++++
Legend: ø: no growth, +: weak bacterial growth, ++: moderate bacterial growth, +++: adequate bacterial growth, ++++: strong bacterial 
growth (!): pigment production
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ing of the plates occurred after 48 hours, the colo-
ny growth and pigment production has shown to 
be independent from the optical density of the ini-
tial inoculum in the range OD580≥0.5, while this 
number was OD580≥0.1 if the reading occurred af-
ter 72 hours (Table I).
3.2. Disk-diffusion quorum-sensing inhibitory assay
The results of the optimization experiments with 
the positive control acridine orange (AO) are pre-
sented in Table II, where the quorum-sensing inhi-
bition zones are shown for the parallel inocula-
tions between QS-sensor strain C. violaceum and 
the AHL-producer strains, and for S. marcescens 
AS-1, respectively (Figure 3). No quantifiable QS-
inhibition zone (i.e. loss of purple violacein pig-
mentation) was detected in case of the CV026-
AHL-producers after 12 hours, at least 24 hours 
were needed for the discoloration to develop, ex-
cept for the S. marcescens AS-1, where minor inhi-
bition was present. Based on our results, the inhi-
bition zone was still subject to change at the 24 
hour-reading of plates, however, the results after 
48 hours may be considered to be final, additional 
incubation and observation did not change the re-
sults. According to the data presented, the Serratia 
model system was the most sensitive for the QS-
inhibitory activity of AO. DMSO was used as a 
negative control, no measureable QS-inhibition 
zone was detected. 
4. Conclusions
The emergence of multidrug resistance in bacteri-
al infections significantly hinders the appropriate 
therapy of patients, and with the current disinter-
est of pharmaceutical companies to develop new 
antibiotics, alternative approaches should be con-
sidered for the therapy of these infections. Quo-
rum sensing is a form of bacterial cell-cell com-
munication, whereby these microorganisms use 
diffusible signal molecules as proxy to detect the 
surrounding cell density and produce metaboli-
cally costly products when the sufficient biomass 
has been reached. Inhibitors of quorum sensing 
may be potent modulators of bacterial virulence, 
eliminating their pathogenic potential, without 
killing them (therefore the selection pressure 
would be lower), however, the development and 
screening for the QS-activity of these compounds 
is not well-established. A standard operating pro-
cedure (SOP) is a designated set of step-by-step in-
structions compiled by relevant (qualified) indi-
viduals or an organization to help carry out vari-
ous operations, aiming to increase precision and 
efficiency. The aim of our study was to character-
ize the appropriate conditions for the disk diffu-
sion-based QS-inhibition assay, consisting of QS-
signal sensor and AHL-producer strains. Based on 
our results, the ideal experimental setting includes 
a modified Luria-Bertani medium (complemented 
with nutrients and microelements), incubation at 
room temperature (25°C) for 48 hours before read-
ing of the results, where the density of the starting 
Table II Quorum-sensing inhibitory activity of acridine orange (OA) in various model systems, corresponding to different 
plate-reading times
 Quorum-sensing inhibition zone diameter (mm±SD)
Bacterial model system 12 hours 24 hours 48 hours 72 hours
C. violaceum CV026 + E. cloacae 31298 ø 13 ± 2.2 14 ± 1.2 14 ± 1.2
C. violaceum CV026 + S. paucimobilis Ezf 10-17 ø 14 ± 1.6 16 ± 0.9 16 ± 0.9
Novosphingobium spp. Rr 2-17 ø 11 ± 2.0 13 ± 1.0 13 ± 1.0
Serratia marcescens AS-1 6 ± 2.3 17 ± 1.5 19 ± 0.8 19 ± 0.8
Figure 3 Quorum sensing-inhibition zones using C. 
violaceum CV026 and E. cloacae 31298 (top) and S. 
marcescens AS-1 (bottom) after 48 hours of incubation
124 Acta Pharmaceutica Hungarica DOI: 10.33892/aph.2019.89.117-125
inocula has less influence of the results of the as-
say. Adherence to the abovementioned criteria 
may aid in improving the reproducibility, compa-
rability and reliability of results obtained by this 
method. 
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